BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22500177)

  • 1. Biological therapy in systemic lupus erythematosus.
    Postal M; Costallat LT; Appenzeller S
    Int J Rheumatol; 2012; 2012():578641. PubMed ID: 22500177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs in early clinical development for Systemic Lupus Erythematosus.
    Postal M; Sinicato NA; Appenzeller S; Niewold TB
    Expert Opin Investig Drugs; 2016; 25(5):573-83. PubMed ID: 26950689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging biological therapies in systemic lupus erythematosus.
    Mount GR; Gilliland WR
    Clin Pharmacol Ther; 2008 Jan; 83(1):167-71. PubMed ID: 18000515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic therapy for systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Discov Med; 2010 Jan; 9(44):20-3. PubMed ID: 20102681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in SLE: the current status.
    Rajadhyaksha AG; Mehra S; Nadkar MY
    J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological therapies in systemic lupus erythematosus].
    Cairoli E; Espinosa G; Cervera R
    Rev Med Chil; 2010 Jul; 138(7):881-7. PubMed ID: 21043085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New.
    Basta F; Fasola F; Triantafyllias K; Schwarting A
    Rheumatol Ther; 2020 Sep; 7(3):433-446. PubMed ID: 32488652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New biologic therapy for systemic lupus erythematosus.
    Ding HJ; Gordon C
    Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity.
    Robak E; Robak T
    Curr Med Chem; 2012; 19(3):438-53. PubMed ID: 22335517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Trends in the Treatment of Systemic Lupus Erythematosus.
    Raja TW; Veeramuthu D; Savarimuthu I; Al-Dhabi NA
    Curr Pharm Des; 2020; 26(22):2602-2609. PubMed ID: 32066358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and emerging treatment approaches to lupus.
    Haubitz M
    Biologics; 2010 Sep; 4():263-71. PubMed ID: 20859453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rituximab in patients with systemic lupus erythematosus: an update.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Galarza-Maldonado C; Sandoval-Cruz M; Zamudio-Huerta L; López-Colombo A; Cervera R
    Autoimmun Rev; 2009 Feb; 8(4):343-8. PubMed ID: 19036350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review.
    Samotij D; Reich A
    Biomed Res Int; 2019; 2019():8142368. PubMed ID: 31396534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus.
    Manson JJ; Rahman A
    Orphanet J Rare Dis; 2006 Mar; 1():6. PubMed ID: 16722594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Lupus Erythematosus: Symptoms and Signs at Initial Presentations.
    Metry AM; Al Salmi I; Al Balushi F; Yousef MA; Al Ismaili F; Hola A; Hannawi S
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):142-150. PubMed ID: 30488801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus.
    Eriksson P; Wallin P; Sjöwall C
    Front Pharmacol; 2019; 10():82. PubMed ID: 30787878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
    Sthoeger Z; Sharabi A; Mozes E
    J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.